Clinical trial
Evaluation of Efficacy and Safety of Oral Baclofen Taking in Comparison With Botulinum Toxin A Injections in Myofascial Pelvic Pain Syndrome. Prospective Multicenter Cohort Study.
NCT05617118 is registered in ClinicalTrials.gov with Saint Petersburg State University, Russia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Efficacy and Safety of Oral Baclofen Taking in Comparison With Botulinum Toxin A Injections in Myofascial Pelvic Pain Syndrome. Prospective Multicenter Cohort Study.
- Lead sponsor
- Saint Petersburg State University, Russia
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- December 1, 2022
- Completion date
- May 1, 2024
- Enrollment
- 52 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic pain, chronic pelvic pain syndrome, myofascial pain syndrome, myofascial trigger point pain, pelvic floor disorders